Gene · 6009
Papers4,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SZT2 variants associated with partial epilepsy or epileptic encephalopathy and the genotype-phenotype correlation. | Front Mol Neurosci | 2023 | 37213690 | PubTator, text mining | PubMed |
| The Ubiquitin-Proteasome System in Tumor Metabolism. | Cancers (Basel) | 2023 | 37190313 | PubTator, text mining | PubMed |
| Anthocyanins Reduce Cell Invasion and Migration through Akt/mTOR Downregulation and Apoptosis Activation in Triple-Negative Breast Cancer Cells: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2023 | 37190229 | PubTator, text mining | PubMed |
| Biological Role and Aberrant Overexpression of Syntenin-1 in Cancer: Potential Role as a Biomarker and Therapeutic Target. | Biomedicines | 2023 | 37189651 | PubTator, text mining | PubMed |
| HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances. | Biomolecules | 2023 | 37189349 | PubTator, text mining | PubMed |
| A Case Report of Pediatric Patient with Tuberous Sclerosis and Radiologically Isolated Syndrome. | J Clin Med | 2023 | 37176724 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis. | Int J Mol Sci | 2023 | 37176098 | PubTator, text mining | PubMed |
| Distinct Traits of Structural and Regulatory Evolutional Conservation of Human Genes with Specific Focus on Major Cancer Molecular Pathways. | Cells | 2023 | 37174700 | PubTator, text mining | PubMed |
| The Complex Interplay between Imbalanced Mitochondrial Dynamics and Metabolic Disorders in Type 2 Diabetes. | Cells | 2023 | 37174622 | PubTator, text mining | PubMed |
| Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents. | Cancers (Basel) | 2023 | 37174088 | PubTator, text mining | PubMed |
| CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells. | Sci Adv | 2023 | 37172090 | PubTator, text mining | PubMed |
| Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer. | NPJ Breast Cancer | 2023 | 37160904 | PubTator, text mining | PubMed |
| mTOR signalling pathway in stem cell bioactivities and angiogenesis potential. | Cell Prolif | 2023 | 37156724 | PubTator, text mining | PubMed |
| The emerging roles of long non-coding RNA in host immune response and intracellular bacterial infections. | Front Cell Infect Microbiol | 2023 | 37153158 | PubTator, text mining | PubMed |
| mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy. | Neurobiol Dis | 2023 | 37149062 | PubTator, text mining | PubMed |
| Binding Modes of Xanthine-Derived Selective Allosteric Site Inhibitors of MTHFD2. | ChemistryOpen | 2023 | 37129313 | PubTator, text mining | PubMed |
| LncRNA DANCR restrained the survival of mycobacterium tuberculosis H37Ra by sponging miR-1301-3p/miR-5194. | Front Microbiol | 2023 | 37125193 | PubTator, text mining | PubMed |
| Mutual connected IL-6, EGFR and LIN28/Let7-related mechanisms modulate PD-L1 and IGF upregulation in HNSCC using immunotherapy. | Front Oncol | 2023 | 37124491 | PubTator, text mining | PubMed |
| Editorial: Identifying the isoform-specific roles of RAS paralogs in health and disease. | Front Cell Dev Biol | 2023 | 37123419 | PubTator, text mining | PubMed |
| Aberrant serum and tissue levels of Beclin1 and mechanistic target of rapamycin (mTOR) proteins in epithelial ovarian cancer. | Medicine (Baltimore) | 2023 | 37115089 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6009/papers?page=19